Crown Princess Mette-Marit placed on waiting list for double lung transplant
Crown Princess Mette-Marit has been placed on a waiting list for a double lung transplant after pulmonary fibrosis worsened; royal duties scaled back amid crisis.
Crown Princess Mette-Marit, 52, has been added to Norway’s national waiting list for a double lung transplant after doctors determined her pulmonary fibrosis has progressed to a life-threatening stage. The princess will step back from official duties while she awaits a suitable donor, the Royal House of Norway said in a statement. Medical teams say the move follows a formal assessment concluding the operation is required as soon as a matched organ becomes available.
Mette-Marit placed on waiting list for double lung transplant
After an ongoing diagnosis of pulmonary fibrosis first disclosed in 2018, Crown Princess Mette-Marit has been evaluated and listed for a double lung transplant due to marked disease progression. Specialists at Oslo University Hospital concluded the condition has reached a severity that warrants listing for transplantation. The royal household confirmed the princess will pause public engagements while remaining under hospital care.
Oslo clinicians describe severity and criteria for listing
Dr. Are Martin Holm, a respiratory specialist overseeing the princess’s case at Rikshospitalet, said the clinical assessment showed a serious deterioration in lung function. Physicians explained that placement on the transplant list typically follows when a patient’s prognosis suggests a high short-term risk without intervention. Medical officials emphasized that transplant allocation will follow standard clinical criteria and prioritise those judged most critically ill.
Waiting-list context and survival outlook in Norway
Norwegian transplant authorities report that a limited number of patients are currently queued for double lung transplants, reflecting both the scarcity of donor organs and stringent medical criteria. The Norwegian Foundation for Organ Donation tracks these cases and confirms that outcomes for similar procedures have been favourable in the short term. Doctors supervising the princess noted survival after comparable transplants is roughly 90 percent at one year, with longer-term survival declining over subsequent years.
Royal family reshapes schedule and travel plans
The health update has prompted immediate changes within the royal household. Crown Prince Haakon cut short an official visit to Japan to return to Norway and will reduce international travel both before and after the operation to remain beside his wife. Princess Ingrid Alexandra has curtailed studies abroad and will take up an exchange semester at the University of Oslo, while Prince Sverre Magnus will continue studies in Europe but remain available to return as needed.
Legal and reputational pressures intensify the crisis
The announcement arrives amid a turbulent period for the royal family that has included reputational controversies in recent months. Documents released earlier this year by the U.S. Department of Justice highlighted past ties between the crown princess and Jeffrey Epstein, leading to a public apology from the princess. In a separate legal matter, Mette-Marit’s son, Marius Borg Høiby, faces criminal charges and remains in custody pending trial outcomes; a court this week denied his release ahead of a verdict expected on June 15, 2026.
Transplant process and fairness of organ allocation
Health officials were clear that the princess will not receive preferential treatment in organ allocation and that Norway’s transplant protocol prioritises urgency and compatibility. Clinicians reiterated that the primary factor in assigning donor lungs is the patient’s medical immediacy and likelihood of benefit. The princess’s team said preparations for surgery will proceed as a suitable organ match is identified, with comprehensive post-operative care planned in line with national practice.
The listing of Crown Princess Mette-Marit for a double lung transplant represents a significant moment for Norway’s royal household and the medical teams involved, as the family balances personal hardship with institutional responsibilities. Public reaction has been measured, with officials urging respect for the princess’s privacy while emphasising transparency about her health status. As the search for a compatible donor continues, the royal family has signalled a period of reduced public activity and heightened focus on care and recovery.
